Need advice in managing cancer immunotherapy cardiotoxicity?

Request Assistance
PROVIDERS
Providers Atezolizumab

Atezolizumab

Trade Name

Tecentriq

Class

Anti-PD-1/PDL-1,PDL-2

Cancer Indication

Urothelial carcinoma, non-small call lung cancer

References

https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761034s001lbl.pdf